\subsection{Table 4}
\textbf{\textit{Table---4 Regression Analysis of Contract Design}} \\
\begin{tabular}{lccccc}
 \hline \hline
& Ordered& Ordered&OLS&OLS with year&OLS with year and\\
& logit & logit&  & fixed effects &firm fixed effects\\
&(1)&(2)&(3)&(4)&(5)\\ \hline
Date & 0.012&0.032&0.005 \\
&[0.039]&[0.043]&[0.006]\\
No specifiable lead product &0.687&0.680&0.126&0.140&0.139 \\ 
&[0.292]**&[0.315]**&[0.047]***&[0.049]***&[0.050]***\\ 
Unknown if specifiable lead product &-0.110&0.031&0.002&-0.011&0.014\\ 
&[0.516]&[0.527]&[0.070]&[0.073]&[0.075]\\
Agreement involves diagnostic&-0.889&-0.794&-0.096&-0.103&-0.097\\
\quad product&[0.540]&[0.545]&[0.061]&[0.064]&[0.065] \\
Agreement involves veterinary&-1.413&-1.336&-0.120&-0.123&-0.107\\
\quad product&[1.034]&[1.037]&[0.090]&[0.095]&[0.096]\\
Carter-Manaster rank of lead&0.003&0.032&0.010&0.009&0.009\\
\quad underwriter of research firm's IPO&[0.070]&[0.077]&[0.011]&[0.011]&[0.011]\\
Number of patents of research firm&&0.006&0.001&0.001&0.001 \\
&&[0.007]&[0.001]&[0.001]&[0.001]\\
Financial Health Index&&0.732&0.075&0.119&0.119\\
&&[0.557]&[0.077]&[0.083]&[0.084]\\
Number of previous research&&-0.016&-0.005&-0.004&-0.019\\
\quad agreements between financing&&[0.352]&[0.051]&[0.053]&[0.054]\\
\quad and research firms\\
Constant&&&-10.739&0.027&-0.12\\
&&&[11.783]&[0.490]&[0.513]\\
Year fixed effects&&&&X&X\\
Financing firm fixed effects&&&&&X\\
\\
Observations&526&483&483&483&483\\
$R^2$&&&0.04&0.07&0.09\\ \hline


\end{tabular}
\input{Notes}